Yuval Cohen

Insider · Chief Executive Officer · CRBP

Yuval Cohen files insider transactions with the SEC as a chief executive officer of Corbus Pharmaceuticals Holdings. We hold 2 disclosed purchases and sales filed since 4 December 2014, 1 of them in the last 90 days.

Files forCRBP
Disclosed buys and sells2 in all, 1 in the last 90 days
Last disclosure10 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed

Filed 3 December 2014 — 7 August 2026Chief Executive Officer · Corbus Pharmaceuticals Holdings 83 Form 4 lines · source: SEC Form 4

Every transaction

83 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only83 of 83 shown


7 Aug 2026	10 Aug 2026SEC Form 4	3 d	sold on the open market	Corbus Pharmaceuticals Holdings	17,000 shares	down −12.9%	down −6.3%
13 Feb 2026	18 Feb 2026SEC Form 4	5 d	sold on the open market	Corbus Pharmaceuticals Holdings	13,871 shares	up +17.2%	up +19.6%
13 Feb 2026	18 Feb 2026SEC Form 4	5 d	sold on the open market	Corbus Pharmaceuticals Holdings	13,871 shares	up +17.2%	up +19.6%
14 Jan 2026	16 Jan 2026SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdings	50,000 shares	up +7.3%	up +6.5%
14 Jan 2026	16 Jan 2026SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	150,000 shares	up +7.3%	up +6.5%
14 Jan 2026	16 Jan 2026SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	150,000 shares	up +7.3%	up +6.5%
14 Jan 2026	16 Jan 2026SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdings	50,000 shares	up +7.3%	up +6.5%
27 Oct 2025	27 Oct 2025SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	8,973 shares	down −47.9%	down −47.9%
27 Oct 2025	27 Oct 2025SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	8,973 shares	down −47.9%	down −47.9%
27 Oct 2025	27 Oct 2025SEC Form 4	0 d	sold on the open market	Corbus Pharmaceuticals Holdings	8,973 shares	down −47.9%	down −47.9%
24 Oct 2025	27 Oct 2025SEC Form 4	3 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	18,660 shares	down −47.5%	down −47.9%
24 Oct 2025	27 Oct 2025SEC Form 4	3 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	18,660 shares	down −47.5%	down −47.9%
24 Oct 2025	27 Oct 2025SEC Form 4	3 d	sold on the open market	Corbus Pharmaceuticals Holdings	18,660 shares	down −47.5%	down −47.9%
14 Feb 2025	18 Feb 2025SEC Form 4	4 d	sold on the open market	Corbus Pharmaceuticals Holdings	7,134 shares	up +4.1%	up +7.9%
31 Jan 2025	4 Feb 2025SEC Form 4	4 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	228,800 shares	down −9.5%	down −8.2%
31 Jan 2025	4 Feb 2025SEC Form 4	4 d	was grantednot a trade	Corbus Pharmaceuticals Holdings	68,100 shares	down −9.5%	down −8.2%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	11,667 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	1,770 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	2,322 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	11,667 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	sold on the open market	Corbus Pharmaceuticals Holdings	11,667 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	1,770 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	sold on the open market	Corbus Pharmaceuticals Holdings	1,770 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	2,322 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	sold on the open market	Corbus Pharmaceuticals Holdings	2,322 shares	down −79.8%	down −79.8%
18 Jun 2024	18 Jun 2024SEC Form 4	0 d	sold on the open market	Corbus Pharmaceuticals Holdings	7,179 shares	down −79.8%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	9,333 shares	down −80.0%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	1,770 shares	down −80.0%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	9,333 shares	down −80.0%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	sold on the open market	Corbus Pharmaceuticals Holdings	9,333 shares	down −80.0%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	1,770 shares	down −80.0%	down −79.8%
17 Jun 2024	18 Jun 2024SEC Form 4	1 d	sold on the open market	Corbus Pharmaceuticals Holdings	1,770 shares	down −80.0%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	16,830 shares	down −82.3%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	12,487 shares	down −82.3%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	16,830 shares	down −82.3%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	sold on the open market	Corbus Pharmaceuticals Holdings	16,830 shares	down −82.3%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	12,487 shares	down −82.3%	down −79.8%
14 Jun 2024	18 Jun 2024SEC Form 4	4 d	sold on the open market	Corbus Pharmaceuticals Holdings	12,487 shares	down −82.3%	down −79.8%
12 Feb 2024	14 Feb 2024SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	73,947 shares	down −61.5%	down −60.6%
12 Feb 2024	14 Feb 2024SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdings	73,947 shares	down −61.5%	down −60.6%
26 Jan 2024	30 Jan 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	7,179 shares	down −70.0%	down −64.8%
26 Jan 2024	30 Jan 2024SEC Form 4	4 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	7,179 shares	down −70.0%	down −64.8%
13 Feb 2023	15 Feb 2023SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	1,989,546 shares	up +108.0%	up +187.7%
10 Aug 2022	11 Aug 2022SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	3,800 shares	up +15.8%	up +11.9%
16 May 2022	16 May 2022SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	10,500 shares	down −0.9%	down −0.9%
9 Mar 2022	9 Mar 2022SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	8,600 shares	down −19.5%	down −19.5%
1 Feb 2022	2 Feb 2022SEC Form 4	1 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	1,489,700 shares	down −37.2%	down −30.0%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	956,500 shares	down −88.6%	down −89.1%
2 Feb 2021	4 Feb 2021SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	956,500 shares	down −88.6%	down −89.1%
11 Nov 2020	12 Nov 2020SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	4,240 shares	down −75.8%	down −78.6%
17 Mar 2020	17 Mar 2020SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	4,300 shares	down −93.0%	down −93.0%
6 Mar 2020	9 Mar 2020SEC Form 4	3 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	639,000 shares	down −93.5%	down −93.0%
12 Nov 2019	12 Nov 2019SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,430 shares	down −93.2%	down −93.2%
12 Aug 2019	12 Aug 2019SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,175 shares	down −95.1%	down −95.1%
13 May 2019	14 May 2019SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	995 shares	down −95.8%	down −95.9%
14 Mar 2019	14 Mar 2019SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,530 shares	down −95.7%	down −95.7%
18 Jan 2019	18 Jan 2019SEC Form 4	0 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	565,000 shares	down −96.1%	down −96.1%
15 May 2018	16 May 2018SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,725 shares	down −95.3%	down −95.3%
14 Mar 2018	15 Mar 2018SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,160 shares	down −95.7%	down −95.7%
4 Jan 2018	5 Jan 2018SEC Form 4	1 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	437,500 shares	down −96.5%	down −96.2%
10 Nov 2017	13 Nov 2017SEC Form 4	3 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,000 shares	down −95.9%	down −95.7%
11 Aug 2017	11 Aug 2017SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,695 shares	down −95.3%	down −95.3%
11 May 2017	12 May 2017SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	3,250 shares	down −95.2%	down −95.3%
16 Mar 2017	17 Mar 2017SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	20,000 shares	down −96.9%	down −96.9%
16 Mar 2017	17 Mar 2017SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	20,000 shares	down −96.9%	down −96.9%
1 Mar 2017	3 Mar 2017SEC Form 4	2 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	377,500 shares	down −96.7%	down −96.8%
22 Nov 2016	20 Jan 2017SEC Form 4	59 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,340 shares	down −96.3%	down −95.7%
22 Nov 2016	23 Nov 2016SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,340 shares	down −96.3%	down −96.3%
6 Oct 2016	7 Oct 2016SEC Form 4	1 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	150,000 shares	down −96.6%	down −97.0%
17 Aug 2016	18 Aug 2016SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdings	20,000 shares	down −91.0%	down −91.8%
17 Aug 2016	18 Aug 2016SEC Form 4	1 d	exercised options overnot a trade	Corbus Pharmaceuticals Holdingsderivative	20,000 shares	down −91.0%	down −91.8%
6 Jun 2016	7 Jun 2016SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,500 shares	down −91.0%	down −90.8%
18 May 2016	19 May 2016SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	2,125 shares	down −87.7%	down −88.4%
7 Jan 2016	11 Jan 2016SEC Form 4	4 d	was grantednot a trade	Corbus Pharmaceuticals Holdingsderivative	530,000 shares	down −78.9%	down −80.2%
23 Nov 2015	24 Nov 2015SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	535 shares	down −83.1%	down −83.3%
13 Nov 2015	16 Nov 2015SEC Form 4	3 d	bought on the open market	Corbus Pharmaceuticals Holdings	850 shares	down −82.6%	down −82.6%
24 Aug 2015	25 Aug 2015SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	550 shares	down −84.6%	down −84.5%
17 Aug 2015	18 Aug 2015SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,025 shares	down −84.6%	down −84.1%
17 Aug 2015	18 Aug 2015SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,075 shares	down −84.6%	down −84.1%
15 Jun 2015	15 Jun 2015SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	900 shares	down −91.2%	down −91.2%
17 Dec 2014	18 Dec 2014SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	400 shares	down −91.3%	down −91.8%
4 Dec 2014	4 Dec 2014SEC Form 4	0 d	bought on the open market	Corbus Pharmaceuticals Holdings	500 shares	down −90.6%	down −90.6%
3 Dec 2014	4 Dec 2014SEC Form 4	1 d	bought on the open market	Corbus Pharmaceuticals Holdings	1,000 shares	down −91.3%	down −90.6%

Both percentages are the stock’s move, not Yuval Cohen’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 83 of the 83 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.